Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety Study of MCI-196 in Patients With Type 2 Diabetes

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients whose fasting blood glucose levels during the observation period are between 130mg/dL and 200mg/dL.~* Patients whose HbA1c is 7.0% or above during the observation period.~Exclusion Criteria:~* Patients with serious cardiac, hepatic or renal complications.~* Patients with serious diabetic complications.~* Patients with complete biliary obstruction or ileus.~* Pregnant, lactating, and probably pregnant patients, and patients who can not agree to contraception.

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- MCI-196 (Type: EXPERIMENTAL): None
- Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).